Latest Sustainable Growth News

Clinuvel Pharmaceuticals has reported its ninth consecutive year of revenue and profit growth, driven by strong sales of SCENESSE® and strategic investment in vitiligo clinical trials. The company also declared its eighth consecutive dividend, underscoring financial resilience.

Clinuvel Pharmaceuticals reports steady financial growth with an 8% rise in revenue and 2% profit increase, while expanding its US commercial footprint and completing recruitment for a pivotal vitiligo trial.

Beam Communications reports a pivotal FY25 marked by the divestment of its Zoleo joint venture, unlocking significant capital and delivering improved margins despite a statutory revenue decline. The company projects positive operating cash flow and growth in FY26.

Verbrec Limited reports its strongest gross margins since 2015 and a return to profitability, alongside a net cash position and a reinstated dividend, signaling renewed confidence amid easing macroeconomic pressures.

EQ Resources has successfully commissioned a third XRT ore sorter at its Saloro tungsten operation, increasing sorting capacity by 50% and improving processing efficiency. An updated ore reserve estimate is expected in early Q4 2025, reflecting operational gains and stronger tungsten prices.

Dicker Data has reported a robust first half of FY25, with revenue climbing 15.7% driven by AI-related deals and an accelerated PC refresh cycle. The company raised its full-year guidance, signaling confidence despite ongoing market challenges.

RAS Technology Holdings reports a robust 31% revenue increase in FY25, marking its second consecutive profitable year, driven by strategic acquisitions and global partnerships that position it for sustained growth.

MONEYME Limited reported a robust FY25 with a 28% increase in its loan book to $1.6 billion and a positive operating cash profit of $24 million, underpinned by improved credit quality and strategic funding initiatives.

Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.

SomnoMed delivered a strong FY25 performance with revenue climbing 22% to $111.5 million and EBITDA turning positive at $9.2 million, boosted by operational improvements and FDA clearance of its Rest Assure device. The company projects further growth in FY26 with expanded manufacturing and ongoing innovation.

RPM Automotive Group reported a mixed FY25 with a slight revenue decline but improved profitability and launched a tyre recycling initiative signaling a strategic shift.

RPM Automotive Group reported a 5% revenue decline and an 8% drop in net profit from continuing operations for FY25, while launching a pioneering tyre recycling program aimed at sustainable growth.